Two Missense Variants Detected in Breast Cancer Probands Preventing BRCA2-PALB2 Protein Interaction

Two Missense Variants Detected in Breast Cancer Probands Preventing BRCA2-PALB2 Protein Interaction

PALB2 (partner and localizer of BRCA2) was initially identified as a binding partner of BRCA2. It interacts also with BRCA1 forming a complex promoting DNA repair by homologous recombination. Germline pathogenic variants in BRCA1, BRCA2 and PALB2 DNA repair genes are associated with high risk of dev...

Full description

Bibliographic Details
Main Authors:	Laura Caleca, Irene Catucci, Gisella Figlioli, Loris De Cecco, Tina Pesaran, Maggie Ward, Sara Volorio, Anna Falanga, Marina Marchetti, Maria Iascone, Carlo Tondini, Alberto Zambelli, Jacopo Azzollini, Siranoush Manoukian, Paolo Radice, Paolo Peterlongo
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2018-10-01
Series:	Frontiers in Oncology
Subjects:	breast cancer breast cancer predisposition genes PALB2 BRCA2 VUS functional analyses
Online Access:	https://www.frontiersin.org/article/10.3389/fonc.2018.00480/full

Similar Items

Functional Characterization of PALB2 Variants of Uncertain Significance: Toward Cancer Risk and Therapy Response Prediction
by: Rick A. C. M. Boonen, et al.
Published: (2020-09-01)

Germline <i>PALB2</i> Mutation in High-Risk Chinese Breast and/or Ovarian Cancer Patients
by: Ava Kwong, et al.
Published: (2021-08-01)

Molecular Mechanisms of PALB2 Function and Its Role in Breast Cancer Management
by: Shijie Wu, et al.
Published: (2020-02-01)

Case Report: Detection of a Novel Germline PALB2 Deletion in a Young Woman With Hereditary Breast Cancer: When the Patient's Phenotype History Doesn't Lie
by: Carmine De Angelis, et al.
Published: (2021-02-01)

Germline PALB2 Mutations in Cancers and Its Distinction From Somatic PALB2 Mutations in Breast Cancers
by: Zhe-Yu Hu, et al.
Published: (2020-08-01)

PALB2 genetik varyasyonlarının meme kanseri yatkınlığı üzerindeki etkilerinin araştırılması
by: Müge YÜKSEL BİLEN, et al.
Published: (2020-03-01)

Allelic variants of breast cancer susceptibility genes PALB2 and RECQL in the Latvian population
by: Philip Hilz, et al.
Published: (2019-07-01)

Editorial: Accomplishments, Collaborative Projects and Future Initiatives in Breast Cancer Genetic Predisposition
by: Paolo Peterlongo, et al.
Published: (2019-08-01)

<em>TOPBP1</em>, <em>CLSPN</em> and <em>PALB2</em> genes in familial breast cancer susceptibility
by: Erkko, H. (Hannele)
Published: (2008)

Familial pancreatic cancer with PALB2 and NBN pathogenic variants: a case report
by: Kodai Abe, et al.
Published: (2021-01-01)

Report of a germline double heterozygote in MSH2 and PALB2
by: Konstantinos Agiannitopoulos, et al.
Published: (2020-10-01)

<em>PALB2</em> and <em>RAP80</em> genes in hereditary breast cancer predisposition
by: Nikkilä, J. (Jenni)
Published: (2013)

Contribution of the <it>PALB2</it> c.2323C>T [p.Q775X] Founder mutation in well-defined breast and/or ovarian cancer families and unselected ovarian cancer cases of French Canadian descent
by: Tischkowitz Marc, et al.
Published: (2013-01-01)

Prevalence and reclassification of BRCA1 and BRCA2 variants in a large, unselected Chinese Han breast cancer cohort
by: Yun Liu, et al.
Published: (2021-01-01)

Novel mutations in actionable breast cancer genes by targeted sequencing in an ethnically homogenous cohort
by: Hosneara Akter, et al.
Published: (2019-09-01)

Recurrent PALB2 mutations and the risk of cancers of bladder or kidney in Polish population
by: Elżbieta Złowocka-Perłowska, et al.
Published: (2021-01-01)

Primary Peritoneal Carcinoma in a BRCA1/2-negative, PALB2-positive patient
by: Ryan Kahn, et al.
Published: (2016-08-01)

A rare PALB2 germline variant causing G2/M cell cycle arrest is associated with isolated myelosarcoma in infancy
by: Angelina Beer, et al.
Published: (2021-09-01)

A PALB2-interacting domain in RNF168 couples homologous recombination to DNA break-induced chromatin ubiquitylation
by: Martijn S Luijsterburg, et al.
Published: (2017-02-01)

The Role of PALB2 in the DNA Damage Response and Cancer Predisposition
by: Thales C. Nepomuceno, et al.
Published: (2017-08-01)

Usefulness and Limitations of Comprehensive Characterization of mRNA Splicing Profiles in the Definition of the Clinical Relevance of BRCA1/2 Variants of Uncertain Significance
by: Elisa Gelli, et al.
Published: (2019-03-01)

Dealing With BRCA1/2 Unclassified Variants in a Cancer Genetics Clinic: Does Cosegregation Analysis Help?
by: Roberta Zuntini, et al.
Published: (2018-09-01)

A Functional Analysis of the Unclassified Pro2767Ser BRCA2 Variant Reveals Its Potential Pathogenicity that Acts by Hampering DNA Binding and Homology-Mediated DNA Repair
by: Maria Valeria Esposito, et al.
Published: (2019-09-01)

Case Report: Co-Existence of BRCA2 and PALB2 Germline Mutations in Familial Prostate Cancer With Solitary Lung Metastasis
by: Tang Tang, et al.
Published: (2020-10-01)

Analysis of Italian <i>BRCA1/2</i> Pathogenic Variants Identifies a Private Spectrum in the Population from the Bergamo Province in Northern Italy
by: Gisella Figlioli, et al.
Published: (2021-01-01)

Frequency of pathogenic germline variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in ductal carcinoma in situ diagnosed in women under the age of 50 years
by: Christos Petridis, et al.
Published: (2019-05-01)

Coexpression of PalbHLH1 and PalMYB90 Genes From Populus alba Enhances Pathogen Resistance in Poplar by Increasing the Flavonoid Content
by: Qiuxian Bai, et al.
Published: (2020-02-01)

Hereditary predisposition to breast cancer – with a focus on <em>AATF</em>, <em>MRG15</em>, <em>PALB2</em>, and three Fanconi anaemia genes
by: Haanpää, M. (Maria)
Published: (2014)

Prevalence and Spectrum of <i>BRCA</i> Germline Variants in Central Italian High Risk or Familial Breast/Ovarian Cancer Patients: A Monocentric Study
by: Jennifer Foglietta, et al.
Published: (2020-08-01)

Prevalence and Spectrum of Germline BRCA1 and BRCA2 Variants of Uncertain Significance in Breast/Ovarian Cancer: Mysterious Signals From the Genome
by: Daniele Fanale, et al.
Published: (2021-06-01)

Molecular and functional characterization of ABRAXAS and PALB2 genes in hereditary breast cancer predisposition
by: Bose, M. (Muthiah)
Published: (2019)

Contralateral Prophylactic Mastectomy in Women with Unilateral Breast Cancer Who Are Genetic Carriers, Have a Strong Family History or Are just Young at Presentation
by: Victoria Teoh, et al.
Published: (2020-01-01)

Some Contributions in Statistical Discrimination of Different Pathogens Using Observations through FTIR
by: Wang, Dongmei
Published: (2009)

Recurrent Mutations in <i>BRCA1</i>,<i> BRCA2</i>,<i> RAD51C</i>,<i> PALB2</i> and <i>CHEK2</i> in Polish Patients with Ovarian Cancer
by: Alicja Łukomska, et al.
Published: (2021-02-01)

GFP-Fragment Reassembly Screens for the Functional Characterization of Variants of Uncertain Significance in Protein Interaction Domains of the <i>BRCA1</i> and <i>BRCA2</i> Genes
by: Laura Caleca, et al.
Published: (2019-01-01)

A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation
by: Marta Castroviejo‐Bermejo, et al.
Published: (2018-12-01)

Germline Missense Variants in <i>BRCA1</i>: New Trends and Challenges for Clinical Annotation
by: Volha A. Golubeva, et al.
Published: (2019-04-01)

The <i>BRCA1</i> c.4096+3A>G Variant Displays Classical Characteristics of Pathogenic <i>BRCA1</i> Mutations in Hereditary Breast and Ovarian Cancers, But Still Allows Homozygous Viability
by: Adalgeir Arason, et al.
Published: (2019-11-01)

Evaluation of Clinical Practices and Needs about Variants of Uncertain Significance Results in Inherited Cardiac Arrhythmia and Inherited Cardiomyopathy Genes
by: Muller, Reka D.
Published: (2019)

Functional Evaluation of Splicing for Variants of Uncertain Significance in Patients with Inherited Retinal Diseases
by: Margarita Mauro-Herrera, et al.
Published: (2021-06-01)

Cannot write session to /tmp/vufind_sessions/sess_cdjbc5ec3k5petu71kplubf29g